Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Ambiq Micro, Inc.NYSE: AMBQ
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $1.74M fell 11.3% year over year, behind the +5.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.6% from the prior quarter.
Context
- Depreciation & amortization amounted to 9.9% of revenue in FY2025, up 1.7 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.3% toward the trailing-twelve-month pace of +5.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 7.22M USD
- Year-over-year change
- +15.5%
- 5-year CAGR
- +30.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.22M | +15.5% |
| FY2024 | 2024-12-31 | 6.25M | -19.1% |
| FY2023 | 2023-12-31 | 7.72M | — |
| FY2021 | 2021-12-31 | 2.61M | +35.6% |
| FY2020 | 2020-12-31 | 1.93M | — |
Depreciation & Amortization vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +5.2% is the 5th highest of 11, against a peer median of -11.1%.
- Depreciation & amortization amounts to 8.5% of revenue for AMBQ, versus a peer median of 5.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $198M USD | -16.5% | +31.3% | 27.8% | |
| LTM Mar 2026 | $24.47M USD | -16.0% | +8.2% | 16.3% | |
| LTM Mar 2026 | $16.72M USD | -10.4% | -0.3% | 6.7% | |
| LTM Apr 2026 | $15.03M USD | +63.9% | +75.8% | 4.7% | |
| LTM Mar 2026 | $9.73M USD | -11.9% | -23.9% | 3.2% | |
| LTM Sep 2026 | $7.26M USD | -19.6% | +3.9% | 4.2% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $6.99M USD | +5.2% | — | 8.5% |
| LTM Mar 2026 | $3.88M USD | +15.0% | +17.2% | 5.0% | |
| LTM Mar 2026 | $3.55M USD | +58.5% | +36.9% | 251.3% | |
| LTM Mar 2026 | $1.19M USD | +44.4% | -24.3% | 2.9% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥1.03M CNY | -95.7% | -55.8% | — |
| Peer median (excluding AMBQ) | — | -11.1% | +6.0% | 5.0% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.97M | 91.01M | 65.54M | 76.07M | 72.51M |
| Cost of Revenue | 29.4M | 60.24M | 46.1M | 51.78M | 46.82M |
| Gross Profit | 21.57M | 30.77M | 19.44M | 24.29M | 25.7M |
| Gross Margin | 42.3% | 33.8% | 29.7% | 31.9% | 35.4% |
| Research & Development | 27.79M | 36.11M | 44.02M | 37.17M | 33.69M |
| Selling, General & Admin | 14M | 19.13M | 26.74M | 27.74M | 33.15M |
| Operating Expenses | 41.79M | 55.87M | 70.76M | 64.9M | 66.84M |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| EBITDA | (18.29M) | (21.85M) | (42.59M) | (33.39M) | (29.21M) |
| EBITDA Margin | -35.9% | -24.0% | -65.0% | -43.9% | -40.3% |
| Operating Income | (20.22M) | (25.1M) | (51.32M) | (40.61M) | (41.14M) |
| Operating Margin | -39.7% | -27.6% | -78.3% | -53.4% | -56.7% |
| Interest Income | 0 | 43K | 0 | 0 | 0 |
| Interest Expense | 4.58M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (4.98M) | (216K) | 1.02M | 980K | 4.72M |
| Income Before Tax | (25.2M) | (25.32M) | (50.3M) | (39.63M) | (36.42M) |
| Pre-Tax Margin | -49.4% | -27.8% | -76.8% | -52.1% | -50.2% |
| Income Tax Expense | 25K | 25K | 30K | 28K | 40K |
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Net Margin | -49.5% | -27.8% | -76.8% | -52.1% | -50.3% |
| EPS (Basic) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| EPS (Diluted) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| Weighted Avg Shares | 13.61M | 248.89M | 10.45M | 13.54M | 7.98M |
| Weighted Avg Shares (Diluted) | 13.61M | 248.89M | 10.45M | 13.61M | 7.98M |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.